申请人:Beecham Group P.L.C.
公开号:US04622342A1
公开(公告)日:1986-11-11
Compounds of formula (II): ##STR1## or salt thereof; wherein R.sup.1 is hydrogen or methyl, R.sup.2 is hydrogen or methyl, R.sup.3 is hydrogen, C.sub.1-12 straight or branched alkyl, C.sub.3-10 cycloalkyl, phenyl(C.sub.1-4)-alkyl or benzyl optionally substituted by C.sub.1-4 alkyl, C.sub.1-4 alkoxy or halogen; R.sup.4 is hydrogen, halogen, hydroxy, C.sub.1-4 alkyl or C.sub.1-4 alkoxy, R.sup.5 is hydrogen or fluorine, R.sup.6 is hydrogen or fluorine, R.sup.7 is halogen; and n is 1 or 2, have anti-obesity and/or anti-hyperglycaemic activity.
该公式(II)的化合物:##STR1##或其盐;其中R.sup.1为氢或甲基,R.sup.2为氢或甲基,R.sup.3为氢,C.sub.1-12直链或支链烷基,C.sub.3-10环烷基,苯基(C.sub.1-4)-烷基或苄基,可选择地被C.sub.1-4烷基,C.sub.1-4烷氧基或卤素取代;R.sup.4为氢,卤素,羟基,C.sub.1-4烷基或C.sub.1-4烷氧基,R.sup.5为氢或氟,R.sup.6为氢或氟,R.sup.7为卤素;n为1或2,具有抗肥胖和/或抗高血糖活性。